Context Therapeutics Inc. (CNTX)

Price & Market Data

Price: $2.56

Daily Change: +$0.163 / 6.36%

Daily Range: $2.44 - $2.62

Market Cap: $238,885,856

Daily Volume: 1,916,218

Performance Metrics

1 Week: 10.26%

1 Month: 6.54%

3 Months: 8.84%

6 Months: 121.5%

1 Year: 265.9%

YTD: 76.57%

About Context Therapeutics Inc. (CNTX)

A detailed overview of Context Therapeutics Inc. (CNTX) reveals a price of 2.56 and a daily shift of +$0.163 / 6.36%. The market cap is currently 238,885,856. Comprehensive performance figures for 1-week (10.26%) and 3-month (8.84%) periods are available.

Company Details

Employees: 15

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

Selected stocks

NeuroOne Medical Technologies Corporation (NMTC)

PennantPark Investment Corporation (PNNT)

Lineage Cell Therapeutics, Inc. (LCTX)

The Glimpse Group, Inc. (GGRP)

Nuvve Holding Corp. (NVVE)